GZMB and neoplasm: Flow cytometry analyses revealed increased frequency (4-fold) of activated CD8 T cells expressing granzyme B in the anti-PD-1 plus CCL21-DC tumor lysate vaccine treatment group in comparison to monotherapy (Figure 2B).